BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/10/2014 12:19:00 PM | Browse: 1281 | Download: 1886
 |
Received |
|
2014-04-05 18:06 |
 |
Peer-Review Started |
|
2014-04-07 19:23 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-05-20 20:34 |
 |
Revised |
|
2014-07-30 18:02 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-09-10 13:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-09-10 13:50 |
 |
Articles in Press |
|
2014-09-10 13:50 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-29 16:06 |
 |
Publish the Manuscript Online |
|
2014-11-10 12:18 |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Bevacizumab maintenance in metastatic colorectal cancer: How long?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alfonso De Stefano, Roberto Moretto, Chiara Alessandra Cella, Francesco Jacopo Romano, Lucia Raimondo, Giovanni Fiore, Francesca Di Pietro, Stefano Pepe, Sabino De Placido and Chiara Carlomagno |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alfonso De Stefano, MD, PhD, Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Via Sergio Pansini, 5, 80131 Naples, Italy. alfonso.destefano@unina.it |
| Key Words |
Metastatic colorectal cancer; Bevacizumab; Maintenance |
| Core Tip |
A colorectal cancer patient with lung metastases received bevacizumab combined with chemotherapy for six months, and then bevacizumab monotherapy as maintenance treatment for more than three years. The patient achieved a complete response without evidence of side effects. He remains relapse free 58 mo after diagnosis. |
| Publish Date |
2014-11-10 12:18 |
| Citation |
De Stefano A, Moretto R, Cella CA, Romano FJ, Raimondo L, Fiore G, Di Pietro F, Pepe S, De Placido S, Carlomagno C. Bevacizumab maintenance in metastatic colorectal cancer: How long? World J Clin Cases 2014; 2(11): 717-723 |
| URL |
http://www.wjgnet.com/2307-8960/full/v2/i11/717.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v2.i11.717 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.